Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;59(10):6260-6280.
doi: 10.1007/s12035-022-02966-5. Epub 2022 Aug 2.

A Review of Molecular Interplay between Neurotrophins and miRNAs in Neuropsychological Disorders

Affiliations
Review

A Review of Molecular Interplay between Neurotrophins and miRNAs in Neuropsychological Disorders

Sara Abdolahi et al. Mol Neurobiol. 2022 Oct.

Abstract

Various neurotrophins (NTs), including nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4, promote cellular differentiation, survival, and maintenance, as well as synaptic plasticity, in the peripheral and central nervous system. The function of microRNAs (miRNAs) and other small non-coding RNAs, as regulators of gene expression, is pivotal for the appropriate control of cell growth and differentiation. There are positive and negative loops between NTs and miRNAs, which exert modulatory effects on different signaling pathways. The interplay between NTs and miRNAs plays a crucial role in the regulation of several physiological and pathological brain procedures. Emerging evidence suggests the diagnostic and therapeutic roles of the interactions between NTs and miRNAs in several neuropsychological disorders, including epilepsy, multiple sclerosis, Alzheimer's disease, Huntington's disease, amyotrophic lateral sclerosis, schizophrenia, anxiety disorders, depression, post-traumatic stress disorder, bipolar disorder, and drug abuse. Here, we review current data regarding the regulatory interactions between NTs and miRNAs in neuropsychological disorders, for which novel diagnostic and/or therapeutic strategies are emerging. Targeting NTs-miRNAs interactions for diagnostic or therapeutic approaches needs to be validated by future clinical studies.

Keywords: BDNF; Brain; CNS; NT3; Neurotrophic Factors; Psychological Disorders.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The interaction between various microRNAs and neurotrophins in different neuropsychological disorders

References

    1. Thomaz A, Jaeger M, Brunetto AL, Brunetto AT, Gregianin L, de Farias CB, Ramaswamy V, Nör C, Taylor MD, et al. Neurotrophin Signal Medulloblastoma Cancers. 2020;12:2542. - PMC - PubMed
    1. László A, Lénárt L, Illésy L, Fekete A, Nemcsik J. The role of neurotrophins in psychopathology and cardiovascular diseases: psychosomatic connections. J Neural Transm. 2019;126:265–278. - PMC - PubMed
    1. Reichardt LF. Neurotrophin-regulated signalling pathways. Philos. Trans. R. Soc. Lond., B. Biol Sci. 2006;361:1545–1564. - PMC - PubMed
    1. Bothwell M (2016) Recent advances in understanding neurotrophin signaling. F1000Res 5:F1000 Faculty Rev-1885 - PubMed
    1. Leopold AV, Chernov KG, Shemetov AA, Verkhusha VV. Neurotrophin receptor tyrosine kinases regulated with near-infrared light. Nat Commun. 2019;10:1–3. - PMC - PubMed

Substances